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Sacral giant cell tumors are rare neoplasms, histologically benign but potentially very aggressive due to the difficulty in achieving a
complete resection, their high recurrence rate, andmetastization capability. Althoughmany treatment options have been proposed,
en bloc excision with tumor-free margins seems to be the most effective, being associated with long term tumor control, improved
outcome, and potential cure. An exemplifying case of a 29-year-old female with progressive complaints of pain and paresthesias in
the sacral and perianal regions, constipation, andweight loss for 6months is presented.The surgical technique for en bloc excision of
a large sacral giant cell tumor through amodifiedKraske procedure withmid-sacrectomy and coccygectomy is described. Complete
resection with wide tumor-free margins was achieved. At 5 years of follow-up the patient is neurologically intact, without evidence
of local recurrence on imaging studies. Amultidisciplinary surgical procedure is mandatory to completely remove sacral tumors. In
the particular case of giant cell tumors, it allows minimizing local recurrence preserving neurovascular function, through a single
dorsal and definitive approach.
1. Introduction
Giant cell tumors (GCT) of bone are rare neoplasms compris-
ing 5% of all primary bone tumors in adults [1] and 5 to 10%
of all benign bone tumors [2], with a 2% to 8.2% incidence
rate [3–5].They usually affect metaepiphyseal regions of long
bones, most often in the knee and radius. Sacrum is the third
most common site of involvement [2] and the most affected
bone of the axial skeleton, accounting for 2–8%of all GCT [6–
8].This type of neoplasm is the secondmost frequent primary
bone-involved tumor in the sacrum [4].
GCT are histologically benign, presenting a slow growth
rate and insidious or clinically silent onset, making early
diagnosis difficult. Usually they exhibit a very large size when
diagnosis is made [8]. They are locally highly aggressive and
present a high recurrence rate and the power to metastasize,
being associated with high morbidity [2, 9–13]. Although
considered benign, they are usually lethal, making them a
complex medical disease [14–16]. Distant metastization is
unusual. The reported incidence of lung metastases from a
histologically proven GCT ranges from 1% to 9% [9, 17–
20]. The local recurrence rate seems to be as high as 33%
[4], reaching more than 50% when intralesional curettage
excision is performed [2, 8]. This may be explained by
difficulties in achieving an early diagnosis, the large tumor
volume at initial presentation, aggressive behavior, poorly
defined tumor margins, and the difficulty to surgically access
these lesions without harming the patient [1, 5, 20]. Local
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malignant transformation has also been reported, accounting
for 16% of primary cases [8, 21].
Magnetic resonance imaging (MRI) and computed to-
mography (CT) scans are useful for early diagnosis and
preoperative planning [22]. Needle biopsy may be reserved
for selected cases [23, 24].
Different treatment options have been used for sacral
GCT [7, 14]. These tumors are relatively resistant to radiation
therapy [4, 14, 15, 17], which on the long term may result
in radiation-induced sarcoma (3–11%) [15, 21, 25, 26]; no
standard chemotherapy protocols are available. This may be
the reason why such treatment options remain controversial
[14, 25].
When located in the sacrum, surgical resection is the pri-
mary treatment modality, being advocated by most authors
[4, 5, 27–29]. En bloc excision with tumor-free margins,
although challenging, is the procedure of choice, once this
constitutes themost effectivemethod for local disease control
and recurrence prevention, improving outcome and provid-
ing the best chance for cure [3, 4, 14, 17, 28].
We present an exemplifying case of a patient harboring
a lesion, which was surgically treated through a modified
Kraske procedure with mid-sacrectomy and coccygectomy,
for en bloc excision of the tumor, with wide tumor-free
margins. A detailed and comprehensive step-by-step surgical
technique overview is presented.
2. Case Presentation
A 29-year-old female, without known past medical his-
tory, was admitted with progressive complaints of severe
pain and paresthesias in the sacral and perianal regions-
for 6 months. In this period of time she also presented
constipation and 5Kg weight loss. These symptoms were
refractory to medical therapy. Pain exacerbated in the
night and by Valsalva maneuvers, causing severe functional
disability.
Physical examination revealed severe pain on palpation
and percussion of the sacral region, without a visible or
palpable lesion or other signs of inflammation. Digital rec-
tal examination revealed a large midline presacral mass,
fixed to the sacrum, with firm consistency and irregular
surface.
The lumbosacral CT and MRI scans showed a large,
expansive, and osteolytic lower and mid-sacral lesion, with
poorly defined margins, extending up to the inferior half of
S2 vertebra.Themass comprised both intra- and extracanalar
components, a ventral extension displacing the rectum ante-
riorly, and dorsal expansion out of the sacral hiatus and
dorsal foramina with soft tissue compromise. It was located
in the midline, slightly more pronounced on the right
side, in between the inferior half of S2 vertebra and the
sacrococcygeal junction. S2 nerve roots were spared but all
nerve roots distal to that were involved by the tumor. The
coccyx was not affected (Figure 1).
Further diagnostic workup was performed including
laboratory studies with tumor markers, chest, abdomen,
and pelvis CT-scan and positron emission tomography. No
abnormalities or other lesions were detected.
After complete characterization of the boundaries of
this sacral solitary lesion, a multidisciplinary elective and
definitive surgery was scheduled with the collaboration
of general and plastic surgeons. No previous biopsy was
performed.
2.1. Operative Technique. The patient was electively operated
by one of the senior authors (A.L.). En bloc excision of the
tumor with wide tumor-free margins through a modified
Kraske procedure with mid-sacrectomy and coccygectomy
was achieved requiring sacrifice of the nerve roots and thecal
sac below the level of S2 nerve roots (Figure 2).
Anesthesia and Positioning. Under general anesthesia the
patient was intubated. Arterial line was placed for blood pres-
sure monitoring. Intravenous dexamethasone and antibiotic
prophylaxis (cefazolin 1 g) were administered preoperatively.
The patient was positioned prone. All pressure points were
covered with padding. Care was taken to avoid elevated
abdominal and airway pressures because this would lead
to inconvenient bleeding. The posterior lumbosacral area,
low back buttock, and posterior thighs were subsequently
sterilized and draped after the skin was dried, giving the
plastic surgeons many options for soft tissue reconstruction
and wound closure at the final step of the surgery. Extra
care was taken at this stage due to the proximity of the anal
orifice to the surgical field, increasing the risk of wound
contamination.
Modified Kraske Procedure. A midline longitudinal skin
incision was carried out posteriorly extending from the
lumbosacral junction to the coccyx. The sacral fascia was
exposed from L5-S1 level to the tip of the coccyx (Figure 3).
These limits were, respectively, superior and inferior to
the tumor and not involved by it. Initially, the fascia opening
and soft tissue dissection were performed inferiorly exposing
the tip of the coccyx and then coming around anterior to it
(Figure 4).
The anococcygeal ligament was transected at a distance
from the anal sphincter and, working ventral to the coc-
cyx, the levator ani muscles were detached from it and
retracted laterally allowing the approach to the presacral
space.
Kraske approach was then performed. Finger dissection
was used to mobilize the rectum creating a plane between
the posterior aspect of the rectum and the ventral part
of the sacrum including the anterior surface of the tumor
(Figure 5).
Once this was accomplished, a coccygectomy was exe-
cuted to provide a better exposure. At this stage, general
surgeons help dissecting Waldeyer’s fasciacreating an avas-
cular plan between the mesorectal fascia propria and the
presacral fascia. This approach provided access between the
mesorectum and the presacral component of the tumor, up
to its superior portion at the level of the inferior half of
S2 segment. Additional release of the lateral ligamentous
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Figure 1: Preoperative T2-weighted contrast enhanced MRI showing an expansive and osteolytic lower and mid-sacral lesion, extending up
to the inferior half of S2 vertebra, with both intra- and extracanalar components and a ventral extension displacing the rectum anteriorly. (a)
Coronal, (b) sagittal, and (c) axial views.
Figure 2: Previewed en bloc excision of the tumor on coronal MRI.
Green and yellow lines represent the limits of the specimen to be
resected, respectively, corresponding to the 3 sacral osteotomies and
the inferior margin around the tumor.
attachments and the inferior portion of the gluteal muscles
allowed a full hand to be insinuated into this plane and
provide further dissection and palpation of the sacrum above
the tumor (Figure 6).
Creation of this space was very important to protect the
rectum and provide tactile feedback and guidance during
the subsequent osteotomies. The obtained dissection plane
was conveniently preserved with large surgical patties with
identification string.
Fascia opening and subperiosteal dissection were then
performed superiorly, exposing the tumor-free dorsal surface
of the upper sacrum at the S1 and S2 levels (Figure 7).
Lower to this level, the sacral periosteum was not incised
or dissected. There, the paraspinal muscles were truncated
leaving an island of sacrospinalis musculature and fat over-
lying the dorsal surface of the sacrum, in an attempt to leave
a tumor-freemargin, due to the tumor infiltration posteriorly
through the dorsal foramina and sacral hiatus. The distal
portion of these muscles remained attached to the sacral
specimen being removed together afterwards (Figure 8).
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Figure 3: Exposition of dorsal fascia from lumbosacral junction to
the tip of the coccyx.
Figure 4: Inferior soft tissue dissection exposing the tip of the
coccyx.
Laterally at the distal sacrum, the gluteus muscle attach-
ments and the sacrospinous and sacrotuberous ligaments
were detached exposing the coccygeus and piriformis mus-
cles, which were divided revealing the lower elements of
the sacral plexus. Subperiosteal dissection was subsequently
carried out over the posterior superior iliac spines allowing
mobilizing the soft tissues to bilaterally expose the sciatic
notches.
At this point the Kraske approach was performed infe-
riorly. Superiorly we have exposed the dorsal bony elements
including the S1 and S2 lamina, as well as posterior superior
iliac spines.
Laminectomy, Thecal Sac, and Nerve Root Ligation. Under
2,5x magnification surgical loupes view, S1 and S2 laminec-
tomies were accomplished using a fine Kerrison rongeur,
allowing exposition of the thecal sac and the tumor-free S1
and S2 nerve roots, going to the respective foramina. At this
point it was very important to make sure the correct level was
identified, not to harm the inappropriate nerve roots, as the
thecal sac was going to be ligated. S1 and S2 nerve roots were
correctly identified. The S2 nerve roots were dissected and
skeletonized on their way to the respective foramen. Tumor
was identified bilaterally in the axilla of the S3 nerve roots
Figure 5: Initial finger dissection used to mobilize the rectum.
Figure 6: Kraske procedure providing access between mesorectum
and presacral component of the tumor.
Figure 7: Superior subperiosteal dissection.
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Figure 8: Soft tissues intentionally left behind and included in the
specimen to be resected.
whichwere too intimately involved by the tumor to be spared.
Tumor capsule was intact.
Thecal sac ligation was then performed with two 2-0 silk
ties passed around the thecal sac, distal to S2 nerve roots
(Figure 9).
A scalpel blade number 15 was then used to sharply cut
the thecal sac, distal to these ties.The distal thecal sac and S3,
S4, and S5 nerve roots were compromised by the tumor, being
sacrificed and included within the specimen to amputate.
A meticulous hemostasis was achieved with coagulation of
epidural venous plexus.
Sacral Osteotomies.Three sacral osteotomies were performed,
two oblique, executed laterally on each side, between the S2
foramen and the ipsilateral greater sciatic notch, followed by
amedial transverse osteotomy, done between the S2 foramina
(Figure 10).
After thecal sac and nerve root ligation was achieved,
bilateral S2 nerve roots were extensively dissected and fol-
lowed on their way to the respective S2 foramina. This
constitutes an important landmark for the execution of lateral
osteotomies, once these extend between the S2 foramina
laterally and the greater sciatic notch. Remaining soft tissues
at the sciatic notch were dissected with monopolar electro-
cautery, enabling a finger to be insinuated superior to the
piriformismuscle into the sciatic notch for further dissection,
and advanced medially to palpate the ventral S2 foramen.
With the finger in place, this important maneuver allowed
guiding and safely performing the lateral osteotomies. Once
the osteotomy has passed from the S2 foramen out to the
sciatic notch, the lateral aspect of the sacrumwas cut allowing
the lateral osteotomies to be completed.This step was accom-
plished bilaterally. Sacroiliac joints were completely spared
and safeguarded.
Having completed the lateral osteotomies, some addi-
tional dorsal gluteal musculature was taken down laterally
with the monopolar electrocautery.The Kraske approach was
again used for guidance of the transverse osteotomy. The
tactile feedback helped to direct the bone cut. This could be
performedwith osteotomes oriented in a transverse direction
Figure 9: Thecal sac ligation distal to S2 nerve roots (red line).
between the S2 foramina, beginning at one S2 foramen and
carrying over to the other. The hand inserted by the Kraske
approach into the presacral space protected the dorsal aspect
of the rectum and again provided additional tactile feedback
for the osteotomy. It helped to guide osteotomes’ trajectory
and sense when the anterior bony cortex was perforated
and bony cut has been completed. Bleeding from the sacral
osteotomies was controlled with bone wax.
En Bloc Resection of the Tumor. At this point, we performed
a coccygectomy and the Kraske approach inferiorly, gluteal
musculature release laterally, thecal sac and nerve root liga-
tion below the level of S2 nerve roots, and lateral and trans-
verse osteotomies superiorly. After thiswas accomplished, the
specimen was tilted dorsally, stretching the S2 nerve roots
so that they could be extensively dissected all the way from
their origin at the thecal sac, freeing them from the remaining
foramina and tracing them out distally.
With additional mobilization, soft tissue attachments
were subsequently released. The remaining deeper muscular
and ligamentous (sacrotuberous and sacrospinous ligaments)
attachments and the distal ends of the S3, S4, and S5 nerve
roots were identified and cut with the monopolar electro-
cautery. This allowed the specimen to be circumferentially
freed and removed from the surgical field, resulting in a
satisfactory en bloc resection with wide tumor-free margins.
The specimen included the tumor with its presacral
component (Figure 11(a)) and the dorsal paraspinal muscles,
left to provide a wide margin posteriorly (Figure 11(b)). A
satisfactory superior margin was also achieved. With this
technique the tumor capsule was not disrupted and S2 nerve
roots were preserved and remained intact along their entire
length (Figure 12).
Hemostasis and Closure. A large dead-space cavity resulted
from the excision of the specimen. Careful hemostasis of the
presacral soft tissue was achieved. Bleeding from the sacral
osteotomies was controlled with bone wax.
General surgeons helped reapproximating the levator ani
muscles. In the final step of the surgery, plastic surgeons
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Figure 10: Representation in a model of the 3 osteotomies performed (green lines) and the level of thecal sac ligation (thin red line). (a)
Posterior view and (b) anterior view.
(a) (b)
Figure 11: En bloc resected specimen. (a) Ventral surface and (b) dorsal surface.
provided soft tissue reconstruction to fill the defect and close
the wound. At this time, the skin incision was lengthened
incorporating the prior midline incision. Adipomuscular
mobilization and rotational flaps of the gluteusmaximuswere
used in the reconstruction of the sacral defect (Figure 13).
Adequate soft tissue reconstruction was achieved, as well
as wound closure in a layered and tensionless fashion. Two
suction drains were left in place. Cefazolin was used in
prophylactic dose (1 gm IV) 60 minutes before surgery and
then every six hours during 24 hour postoperatively.
3. Results
En bloc excision with wide tumor-free margins of this large
lower and mid-sacral mass was achieved through a modified
Kraske procedure withmid-sacrectomy and coccygectomy. It
required sacrifice of the nerve roots and thecal sac below the
level of S2 nerve roots.
As previewed on the preoperative MRI scan, the tumor
location at the lower and mid-sacrum and its limits (superi-
orly: the inferior half of S2 segment; inferiorly: the superior
half of S5 segment; laterally: sparing the sacroiliac joints;
ventrally: in intimate relation with the rectum which was
anteriorly displaced; dorsally: invading the posterior surface
of the sacrum out through the sacral hiatus and dorsal
foramina; inside the sacral canal: affecting the thecal sac and
nerve roots below the S2 nerve roots level) were corroborated
with the intraoperative findings and allowed to precisely
define the boundaries of the specimen to be removed,
keeping distance from the tumor capsule and sacroiliac
joints.
There were no procedure-related complications. Histo-
pathological analysis of the resected specimen revealed a
benign GCT (Figure 14).
The patient was discharged home presenting constipation
and urinary retention. Constipation resolved with laxatives.
Concerning urinary retention she underwent a suitable reha-
bilitation program, with intermittent self-catheterization,
and perineal muscular tonification workout with voluntary
sphincter contraction exercises. This resolved within five
months following surgery. At five years of follow-up, the
patient still complains of minimal subjective numbness in the
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Figure 12: S2 nerve roots were preserved and remained intact along
their entire length.
Figure 13: Rotational flaps of the gluteus maximus provided for soft
tissue reconstruction and wound closure.
perianal region, without any other neurological deficits and
performing well in all living activities, being inclusively able
to sit for long periods of time without pain.The postoperative
MRI scan showed complete resection of the distal sacrum
and coccyx with no evidence of residual lesion. Last follow-
up MRI was performed five years after surgery showing no
recurrence of the tumor (Figure 15).
4. Discussion
Management of GCT of the sacrum is complex and challeng-
ing from diagnosis to treatment. This is due to their rarity
and heterogeneous clinical scenarios and because the surgical
procedures generally involved are extensive and aggressive,
aiming for complete tumor resection and potential cure.
These procedures may be extra-demanding not only
because of the aggressive nature and behavior of GCT,
but also once the majority of them are diagnosed in an
advanced stage of the disease, exhibiting large volumes and
sometimes, poorly definedmargins.Thismay create technical
difficulties in surgical access and tumor resection, due to
the surrounding anatomical constraints and nearby noble
structures to preserve [1, 5, 20, 30]. For this reason, proper
patient selection is paramount.
A detailed clinical and neurological assessment including
digital rectal examination is mandatory for helping to estab-
lish an early diagnosis. Investigation for metastatic disease
should always be performed in order to decide the best
treatment option (curative versus palliative).
Tumors’ radiological appearance and their location,
accessibility, local extension, and involvement of adjacent
neurovascular structures are of paramount importance and
should always be kept inmind before considering performing
a biopsy, once this is an invasive, noninnocuous procedure,
with well-known risks of tissue contamination through the
biopsy tract, hemorrhage, and infection [14, 31]. CT-guided
fine-needle biopsy may be a helpful tool for the histological
diagnosis [14] in selected cases: whenever this informa-
tion is preoperatively relevant for potentially changing or
influencing the treatment approach; for unresectable lesions;
or in patients with significant comorbidity, precluding a
more aggressive surgery (if required to indicate adjuvant or
palliative therapy). Biopsy is useful to reach the differential
diagnosis of sacral lesions (metastases, giant cell tumor, chor-
doma, teratoma, and chondrosarcoma). In this particular
case, we adopted a direct approach to the lesion, without
previous biopsy, because the patient had a good general
medical condition; there were no other documented lesions;
the tumor was well circumscribed, surgically accessible with
the possibility of reaching en bloc resection with tumor free
margins without further neurological deterioration. Having
this in mind, the surgical approach would be the same
regardless of the biopsy result.
Preoperatively, it is important to precisely define the goal
of surgery and the anatomical boundaries to be respected
intraoperatively. It is crucial to accurately assess several ima-
giological parameters such as the level of sacral involvement,
infiltrated structures (sacral canal, thecal sac, nerve roots,
muscles, ligaments, vascular and visceral structures, and
sacroiliac joints), and ventral and dorsal extensions. This is
essential to establish a preliminary diagnosis and decide the
best surgical approach and for surgical planification of the en
bloc resection [22].
Several treatment options have been proposed: intratu-
moral curettage plus radiotherapy, possibly aided by preop-
erative embolization, the use of osteoclast inhibiting drugs
(bisphosphonates), and cryosurgery with liquid nitrogen,
limited by the risk of injury to adjacent neural structures in
sacral tumors.
According to some authors, en bloc excision is the gold
standard procedure for sacral GCT which present radio-
logical criteria denoting the potential aggressiveness of the
tumor: poorly defined margins, cortical bone destruction,
and soft tissue extension by expansive tumor growth [6, 30,
32–34].
The presented surgical technique is an optimal and
effective strategy to completely remove lower and mid-
sacral tumors. It is indicated for the benign but highly
aggressive sacral GCT and can also be applied to primary
malignant bone tumors of the sacrum. In the particular case
of GCT, themodifiedKraske procedure withmid-sacrectomy
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Figure 14: (a)Hematoxylin-eosin stained tissue demonstrated a highly cellular, solid neoplasmconsisting ofmononuclear cells and osteoclast-
like giant cells; (b) intense immunohistochemical staining for CD68 (KP1).
(a) (b)
Figure 15: MRI scan evaluation 5 years after surgery, showing no recurrence of the tumor. (a) Coronal and (b) sagittal views.
and coccygectomy allows maximizing local tumor control,
minimizing the risk of local recurrence, and providing
possible cure, giving the possibility to preserve neurovascular
function, by this mean decreasing morbidity and improving
the final outcome.
During the surgery of lower or mid-sacral tumors,
several nuances must be taken into account. Only the
affected sacral nerve roots should be sacrificed, and the
expected neurological outcome needs to be preoperatively
predicted and discussedwith the patient [33, 35–37]. Also, the
sacroiliac joints should be spared to avoid spinal instability
[38–42].
Given the complexity of evaluation, treatment, and
management of GCT, a coordinated multidisciplinary team
approach to the problem, involving neurosurgeons, gen-
eral surgeons, and plastic surgeons, working together in
specialized units, has proved useful [33]. This collabora-
tion is essential helping to select and implement surgical
treatment to minimize the risk of perioperative complica-
tions. General surgeons are important for the approach and
mobilization of the rectum from the tumor and ventral
sacrum.
The used modified Kraske procedure (midline incision
rather than left parasacral as it was described in the original
technique) provided an excellent surgical access between
the mesorectum and the presacral component of the tumor,
allowing a safe and complete tumor removal to be achieved
without morbidity [31, 43]. Also plastic surgeons collabora-
tion is highly significant for soft tissue reconstruction and
wound closure. The extensive resection of sacral tumors is
always associated with large defects or dead-space cavities,
and to optimize surgicalwoundoutcome,minimizing the risk
ofwounddehiscence or infection, their intervention is crucial
[44–48]. We adopted the closure technique described by Yao
et al. [49]. This technique has many advantages over other
reconstruction and closure approaches: it keeps a native and
robust blood supply of the flaps, creates a protective tissue
layerwhile also absorbing cavity effusion, and reduces seroma
formation, wound dehiscence, and rate of infection, which
can reach as much as 38% [49].
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The major benefits of this surgical technique are the
capability to successfully achieve complete surgical resection
with wide tumor-free margins, protect the presacral vascular
and visceral structures, and accomplish these goals through
a single and definitive dorsal approach. Trying to accomplish
complete removal of GCT during the initial surgery is very
important and should be, if possible, the main goal. This
allows reaching a favorable prognosis, minimizing the risk of
recurrence [28]. Nevertheless, careful selection of the patients
amenable to this approach is a must. Low or mid-sacral
tumors constitute the perfect indication.
5. Conclusion
Surgical treatment of sacral GCT is challenging and tech-
nically demanding, due to the complex regional anatomy
in this area, and the advanced stage of disease by the time
diagnosis ismade. Awell-coordinatedmultidisciplinary team
approach, working in specialized units, is mandatory.
Early diagnosis, complete (en bloc) surgical resection
with tumor-free margins, and a comprehensive treatment are
essential for local tumor control, best long-term prognosis,
and improved outcome with possible cure.
The difficult conflict between patient’s functional integ-
rity and the cure of the disease must be preoperatively well
weighted and discussed with the patients and the team.
An accurate preoperative planning must precisely locate
the tissues involvement (bone,muscle, nerves, and joints) and
delineate the extension of the area to be resected.
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